Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the deadliest forms of cancer.

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models.

Jeddah: In a notable shift in the concept of a flagship Corporate Social Responsibility (CSR) initiative, Bupa Arabia for ...

Increased use of organoids in cancer research: The Würzburg lighthouse project "Preclinical Models" is working towards this ...

Retinoic acid suppresses immune defenses against cancer, but a new drug KyA33 boosts vaccine success and slows tumor growth ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

NAYA's European Hub to Accelerate Clinical Development of its Astatine-211 Targeted Alpha Therapies and Multispecific ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread.

By ending the ALARA principle, DOE opens the door to science-based radiation regulation that could restore nuclear power’s competitiveness.

A study that was published in recent weeks has given the world a sobering view of the number of cancer diagnoses that are ...

Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.